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ABSTRACT
Hypoglycaemic and antihyperglycemic activity of oil palm Elaeis guineensis fruit extract on normal and Streptozotocin-
induced diabetic rats was studied. The oil palm fruit extract (OPF) were administered orally at different concentrations (100, 
200 and 500 mg kg-1 b.w.) in fasting and post-prandial rats. Hypoglycaemia was not observed in the group of normal rats 
treated with OPF. In fasting rats, OPF (500 mg kg-1 b.w.) has caused the blood glucose level (BGL) to reduce significantly. 
For post-prandial diabetic rats, the antihyperglycemic activity was observed after OPF treatment at concentrations 200 
and 500 mg kg-1. Chronic OPF treatments (for 28 days) had increased the diabetic rat’s body weight and reduced BGL as 
well as improved plasma insulin secretion. The result of this study suggests E. guineensis palm fruit extract show evidence 
of antihyperglycemic properties from the reduction of the BGL in diabetic rats.
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ABSTRAK
Aktiviti hipoglisemik dan antihiperglisemik ekstrak buah kelapa sawit Elaeis guineensis terhadap tikus normal dan 
tikus diabetik aruhan- Streptozotocin dikaji. Ekstrak minyak buah kelapa sawit (OPF) diberi secara oral pada kepekatan 
berbeza (100, 200 dan 500 mg kg-1 b.w.) kepada tikus puasa dan posprandial. Hipoglisemia tidak berlaku dalam kumpulan 
tikus normal yang dirawat dengan OPF. Dalam tikus puasa, OPF (500 mg kg-1 b.w.) telah menyebabkan aras glukosa 
darah (BGL) turun secara bererti. Bagi tikus diabetik posprandial, aktiviti anti hiperglisemik telah diperhatikan selepas 
rawatan OPF pada kepekatan 200 dan 500 mg kg-1. Rawatan OPF secara kronik (selama 28 hari) meningkatkan berat 
badan tikus diabetik dan menurunkan BGL secara bererti serta memperbaiki rembesan plasma insulin. Keputusan kajian 
ini mencadangkan, ekstrak buah kelapa sawit E. guineensis menunjukkan sifat antihiperglisemik dengan penurunan BGL 
tikus diabetik.
Kata kunci: Elaeis guineensis; ekstrak buah kelapa sawit; aras glukosa darah; hipoglisemik; antihiperglisemik
INTRODUCTION
Diabetes mellitus is a chronic metabolic disorder which 
affects more than 300 million people worldwide. The 
main characteristic of this disease includes hyperglycemia, 
polydipsia, polyphagia, polyurea, muscle weakness, 
weight loss and dyslipidemia. Major factors contributing 
to diabetes are imbalance diet, high sugar intake, less 
healthy lifestyle as well as family genetic history. Despite 
these major factors, the role of oxidative stress in causing 
diabetics had also been reported (West 2000). Oxygen 
free radicals such as superoxide anion (O2
∙-), hydroxyl 
radical (OH∙), hydrogen peroxide and singlet oxygen are 
among the first damaging species generated in islet cell. 
High concentration of oxygen free radicals may result 
in significant damage to pancreatic ß-cell structures and 
further disrupting its ability to produce insulin. This 
phenomenon is known as oxidative stress (West 2000).
Phenolic compounds are ubiquitous in all plant organs. 
Human consume various type of plants as their diet hence 
making the phenolic compounds as integral part of human’s 
life. Recent interests in phenolics are due to its antioxidants 
activities and radical scavenging capabilities which create 
potential benefits on human health (Gallagher et al. 2003; 
Xia & Wang 2006). Oil palm (Elaeis Guineensis) was 
the number one oil producing crop in Malaysia. It is the 
major source of edible oils. The utilisation of oil palm as 
potential source of polyphenols and antioxidant compounds 
have been reported widely (Nagendran et al. 2005; Neo 
et al. 2010).
Previously much attention has focused on oil palm 
fruits carotenes and vitamin E (tocopherols and tocotrienols) 
for their anti-proliferative effects on tumor cells (Kausar 
et al. 2003). To date, the attention has switched to the use 
of various types of phenolic compounds found in oil palm 
including ferulic, hydroxybenzoic, coumaric, chlorogenic, 
protocatechuic and gallic acid as well as narirutin, 
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hesperidin and catechin for their possibility in treating 
chronic diseases (Neo et al. 2010; Sundram et al. 2003). 
Nevertheless, the antidiabetic effects of oil palm fruits on 
blood glucose regulation are yet to be known. Hence this 
report in general was undertaken to determine the effects 
of oil palm fruits phenolic extract on glucometabolism of 
STZ-induced diabetic rats.
MATERIALS AND METHODS
SAMPLES PREPARATION
Ripe palm fruits were collected from Universiti Putra 
Malaysia (UPM) plantation. The fruits were cut into slices 
to remove the mesocarp from the nut. Then the mesocarps 
were dried at 40oC overnight. This temperature is 
sufficient to remove the water from the mesocarps without 
compromising its texture. The next day the dried flesh were 
grind into small pieces and subject to Soxhlet extraction 
using n-hexane to remove the oil.
EXTRACTION
The oil palm fruit extract (OPF) preparation was conducted 
by adapting the procedure highlighted by Wang & Halliwell 
(2001). Briefly one gram of dried oil palm mesocarp was 
mixed with 40 ml of 60% aqueous ethanol (Merck). Next 
5 ml of 6 M HCl was added into the mixture prior reflux. 
After refluxing for 2 h, the extract was cooled, filtered and 
made up to 50 ml with 60% ethanol. 
ANIMAL STUDY AND DIABETES INDUCTION
Male Sprague-Dawley rats (weighed 170-220 g) were 
used in the present study. The rats were housed in clean 
cages covered with stainless steel cover and kept in well 
ventilated room with 12-h light/12-h dark cycle. Prior to 
the examination all rats were acclimatized for one week 
where standard rat pellets (Gold Coin, Selangor, Malaysia) 
and water was supplied ad libitum during acclimatization. 
This study was conducted in accordance to the Animal 
Care and Use Committee (ACUC) Faculty of Medicine and 
Health Sciences, Universiti Putra Malaysia guidelines and 
have received unconditional ethical approval from the same 
committee (ACUC No: UPM/FPSK/PADS/BR-UUH/00406).
The rats were induced for diabetes using Streptozotocin, 
STZ (Sigma). At day 7 the rats were injected intraperitoneally 
(i.p) with 60 mg kg-1 body weight (b.w) of STZ dissolved in 
water after an overnight fasting. Three days later the rat’s 
BGL was checked and rats with a fasting BGL higher than 7.8 
mmol L-1 were considered as having diabetic and therefore 
selected for further study. The rats were divided into seven 
different groups (n = 6 per group) as follows:
1. Group 1 – Normal control rats (NC)
2. Group 2 – Diabetic control rats (DC)
3. Group 3 – Diabetic rats receiving 100 mg kg-1 b.w of 
OPF (OPF100)
4. Group 4 – Diabetic rats receiving 200 mg kg-1 b.w of 
OPF (OPF200)
5. Group 5 – Diabetic rats receiving 500 mg kg-1 b.w of 
OPF (OPF500)
6. Group 6 – Diabetic rats receiving 500 mg kg-1 b.w of 
Metformin (Met)
7. Group 7 – Diabetic rats receiving 30 mg kg-1 b.w of 
Glibenclamide (Gb)
EFFECTS OF OPF ON RATS BGL
The rats were examined for their fasting and post-prandial 
BGL. For the fasting BGL, the rats were fasted overnight 
prior to the examination. In contrast, for the post-prandial 
BGL, rats had free access to water and pellet diet but 
were fasted for 1 h prior to the examination. The BGL 
was determined before and after 2, 4 and 6 hours of OPF 
administration. The blood was collected from the rat’s tail 
tip and the glucose level was determined using a glucometer 
(Accu-check advantage, Roche Diagnostic, Germany). 
CHRONIC TREATMENT
For chronic treatment, the rats were given OPF orally using 
intragastric gavage for 28 days. Body weight and BGL were 
monitored at day 7 and 28 along the treatment period. At 
the end of the study, the rats were sacrificed after blood 
collection and the blood were used to determine the insulin 
level using radioimmunoassay (RIA) kit (GE Healthcare, 
Uppsala, Sweden).
STATISTICAL ANALYSIS
The main variables were analysed descriptively using mean 
and 1 standard deviation. One-way ANOVA (GraphPad 
Prism 5) at 5% significance level (p < 0.05) was used to 
compare the mean differences in OPF extract treated groups 
and control group. To further investigate the significant 
results between pairs, Dunnet post hoc test was also 
conducted.
RESULTS
EFFECTS OF OPF ON NORMAL, FASTING AND 
POST-PRANDIAL RATS BGL
The hypoglycemic effects of OPF extract on BGL in 
normal rats are shown in Table 1. BGL of normal rats 
was not significantly increased or decreased in all 
groups. In contrast, rats treated with metformin showed 
significant reduction of blood glucose level after 2, 
4 and 6 hours of administration. The same result was 
observed in glybenclamide treated group where the BGL 
was significantly reduced after 2, 4 and 6 hours of drug 
administration. The results suggest that hypoglycaemia 
was not present in the OPF treated group. 
Table 2 shows the effects of different doses of OPF 
extract on fasting BGL of STZ-induced diabetic rats. The 
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BGL was significantly reduced at the highest concentration 
of OPF (500 mg kg-1 b.w) after 2, 4 and 6 hours of extract 
administration. The results in OPF groups receiving 
500 mg kg-1 b.w were comparable to metformin group in 
which a significant BGL reduction was observed after 2, 4 
and 6 hours of administration. The glybenclamide treated 
group however did not show any significant fall in their BGL. 
The effects of OPF extract on postprandial BGL of 
diabetic rats are shown in Table 3. The OPF treatment 
showed a significant BGL reduction in 200 and 
500 mg kg-1 b.w OPF treated groups. Group treated with 
200 mg kg-1 b.w OPF showed a significant BGL reduction 
after 4 and 6 hours of OPF treatment while 500 mg kg-1 
b.w OPF treated group showed a significant BGL reduction 
TABLE 1. Effects of oil palm fruit extracts on normal rats BGL
 
Treatment
 
Dose/
      BGL/mmol.l-1
  
mg kg-1 b.w. 
   0 hr 2 hrs 4 hrs 6 hrs
 Normal control - 3.91 ± 0.25 3.73 ± 0.27 4.25 ± 0.28 3.80 ± 0.16
  100 4.01 ± 0.33 3.54 ± 0.10 3.50 ± 0.33 3.71 ± 0.25
 Extract 200 3.86 ± 0.25 3.58 ± 0.22 3.79 ± 0.13 3.69 ± 0.15
  500 4.20 ± 0.26 3.95 ± 0.34 3.75 ± 0.29 3.74 ± 0.18
 Metformin 500 3.84 ± 0.21 2.78 ± 0.11** 1.73 ± 0.12** 2.40 ± 0.16**
 Glybenclamide 30 3.95 ± 0.18 3.20 ± 0.15* 2.68 ± 0.14** 3.14 ± 0.13**
 *p < 0.05, **p < 0.01 as compared to pre-treatment hour (0 hr)
TABLE 2. Effects of oil palm fruit extract on fasting diabetic rats BGL
 
Treatment
 
Dose/
      BGL/mmol.l-1
  
mg kg-1 b.w. 
   0 hr 2 hrs 4 hrs 6 hrs
 Diabetic control - 19.17 ± 0.75 25.37 ± 0.65 24.55 ± 0.27 23.90 ± 0.68
  100 19.47 ± 0.47 20.25 ± 0.85 19.50 ± 0.76 20.17 ± 0.79
 Extract 200 19.32 ± 0.80 21.02 ± 0.91 18.05 ± 0.50 18.33 ± 0.71
  500 19.22 ± 0.91 16.82 ± 0.48* 11.12 ± 0.35*** 8.03 ± 0.44***
 Metformin 500 19.45 ± 0.90 15.28 ± 0.45* 9.83 ± 2.14*** 6.05 ± 0.40***
 Glybenclamide 30 19.13 ± 0.59 19.18 ± 0.68 20.27 ± 1.12 20.17 ± 0.88
 *p < 0.05, ***p < 0.001 as compared to pre-treatment hour (0 hr)
TABLE 3. The effect of oil palm fruit extract on post-prandial diabetic rats BGL
 
Treatment
 
Dose/
      BGL/mmol.l-1
  
mg kg-1 b.w. 
   0 hr 2 hrs 4 hrs 6 hrs
 Diabetic control - 26.05 ± 0.70 27.90 ± 0.77 26.52 ± 0.68 25.53 ± 0.73
  100 26.63 ± 1.31 23.22 ± 1.47 26.35 ± 0.68 25.87 ± 0.89
 Extract 200 26.13 ± 0.52 24.98 ± 1.13 20.33 ± 1.49* 18.38 ± 0.61***
  500 26.10 ± 1.04 21.22 ± 0.79* 19.98 ± 1.32* 12.52 ± 0.89***
 Metformin 500 26.72 ± 0.84 25.35 ± 0.68 15.48 ± 1.34*** 6.90 ± 0.69***
 Glybenclamide 30 26.60 ± 1.30 27.75 ± 0.51 24.62 ± 1.65 24.30 ± 0.57
 *p < 0.05, ***p < 0.001 as compared to pre-treatment hour (0 hr)
after 2, 4 and 6 hours of OPF administration. Both treatment 
groups showed a comparable result with metformin treated 
group in which the BGL reduced significantly after 4 and 
6 hours of metformin administration. The glybenclamide 
treated group on the other hand did not show any significant 
result along the treatment period.
EFFECTS OF CHRONIC TREATMENT ON BODY WEIGHT, 
BGL AND INSULIN SECRETION
Figure 1 shows the chronic effects (28 days) of OPF 
treatment on body weight of normal and STZ-induced 
diabetic rats. The body weight of normal control rats 
increased significantly (p < 0.001) during the treatment 
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with 32.5% increment at day 28. On the other hand, a 
significant fall was observed in body weight of diabetic 
control group (26.9%, p < 0.001) as well as the group 
receiving 100 (25.5%, p < 0.001) and 200 (9.9%, p < 
0.05) mg kg-1 b.w of OPF extract. In contrast, a significant 
increase in body weight was observed in group treated with 
500 mg kg-1 b.w OPF (22.9%, p < 0.001). In metformin 
treated group, there was no significant difference in body 
weight observed along the treatment period.
The antihyperglycemic activity of OPF extract on the 
BGL of normal and STZ-induced diabetic rats are shown in 
Figure 2. The normal control as well as the metformin and 
200 mg kg-1 b.w OPF treated groups showed no significant 
differences in fasting BGL along the treatment period. 
Meanwhile, a significant increase in BGL was observed in 
diabetic control and 100 mg kg-1 b.w OPF treated groups in 
which the differences were 45.5% (p < 0.001) and 19.0% 
(p < 0.001) respectively. In contrast, the group treated with 
500 mg kg-1 b.w of OPF showed a significant decline in BGL 
by 31.5% (p < 0.001) at the end of experiment.
Figure 3 shows the chronic effect of OPF treatment on 
the plasma insulin level of normal and STZ-induced diabetic 
FIGURE 1. Body weight changes of rats over 28 day’s chronic treatment. NC = normal control rats, DC = diabetic control rats, 
OPF100 = rats receiving 100 mg kg-1 b.w of OPF extract, OPF200 = rats receiving 200 mg kg-1 b.w of OPF extract, OPF500 = rats 
receiving 500 mg kg-1 b.w of OPF extract, MET = rats receiving metformin and GB = rats receiving glybenclamide. 
Values represent mean ± SD. *p < 0.05, ***p < 0.001 as compared to day 0
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FIGURE 2. Blood glucose level changes of rats over 28 day’s chronic treatment. NC = normal control rats, DC = diabetic control rats, 
OPF100 = rats receiving 100 mg kg-1 b.w of OPF extract, OPF200 = rats receiving 200 mg kg-1 b.w of OPF extract,  
OPF500 = rats receiving 500 mg kg-1 b.w of OPF extract, MET = rats receiving metformin and GB = rats receiving glybenclamide. 
Values represent mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001 as compared to day 0
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rats. Almost all experimental groups showed no significance 
differences in their plasma insulin levels except for groups 
receiving 500 mg kg-1 b.w of OPF extract. The extract was 
shown to increase the plasma insulin level significantly 
by 74.1% (p < 0.05) when compared to its baseline.
DISCUSSION
EFFECTS OF OPF ON NORMAL, FASTING AND 
POST-PRANDIAL RATS BGL
STZ has been used to chemically induce hyperglycemia 
in rats and mice (Rosalina et al. 2011; Sachdewa et al. 
2003). It is taken up by pancreatic ß-cells through glucose 
transporter (GLUT2). It generates reactive oxygen species, 
causing alkylation of deoxyribonucleic acid (DNA) and 
evokes other deleterious changes in cells. DNA damage 
induces activation of poly adenosine diphosphate (ADP)-
ribosylation which leads to the depletion of cellular 
nicotinamide adenine dinucleotide (NAD+) and further 
reduction of the adenosine triphosphate (ATP) (Pieper 
et al. 1999). Enhanced ATP dephosphorylation supplies 
a substrate for xanthine oxidase (XOD), resulting in the 
formation of superoxide anion. As a result of superoxide 
anion generation, hydrogen peroxide and hydroxyl radicals 
are formed. Furthermore, STZ also liberates toxic amount 
of nitric oxide (NO). NO inhibits aconitase activity and 
participates in DNA damage. As the result, ß-cells undergo 
destruction and inhibit insulin synthesis and secretion.
In our study the rats were injected with 60 mg kg-1 b.w 
STZ. It was reported that STZ dose of 40-60 mg kg-1 b.w on a 
single intravenous injection produced an IDDM type of rats 
due to the damage of ß-cells of pancreatic islet (Szkudelski 
2001). Glybenclamide and metformin were used as positive 
control in this study to evaluate the possible mechanism 
of action in reducing the hyperglycemia. Metformin is a 
common drug prescribed to a diabetic patient. Its main 
mechanism of action is through enhancement of glucose 
uptake in muscle and reducing hepatic gluconeogenesis, 
thereby reducing glucose level in blood stream (Chehad 
& Mooradian 2000). Glybenclamide on the other hand 
is classified into sulphonylurea group of drug. Its mode 
of action is by stimulation of Ca2+ influx into pancreatic 
ß-cells which later results in synthesis and secretion of 
insulin (Malaisse 1999). Our data showed no significant 
decrease in hyperglycemia in all diabetic rat groups treated 
with glybenclamide (Table 1, 2 and 3). This may be resulted 
from the damaged ß-cells due to STZ action. As the ß-cells 
are destroyed they lose ability to produce enough amount 
of insulin to tackle down hyperglycemia.
In normal rats, the results showed no significance 
hypoglycaemic activity in all rat groups treated with the oil 
palm fruit extract; whereas metformin and glybenclamide 
has a significant hypoglycaemic activity after 2 h of drug 
administration (Table 1). The results indicated that all doses 
of oil palm fruit extract did not have hypoglycaemic activity 
in normal rats. This finding shows a bright potential of OPF 
as future antidiabetic agents as the current conventional 
drugs treatment exhibit hypoglycaemic activity and it 
is considered as a major limitation for the conventional 
drugs. In fasting and post-prandial diabetic rat groups, the 
results showed a decreasing pattern in hyperglycemia for 
rats treated with the OPF and metformin. In fasting diabetic 
rats the OPF exhibited a significant antihypergylcemic 
FIGURE 3. Plasma insulin level of rats over 28 day’s chronic treatment. NC = normal control rats, DC = diabetic control rats,  
OPF100 = rats receiving 100 mg kg-1 b.w of OPF extract, OPF200 = rats receiving 200 mg kg-1 b.w of OPF extract, OPF500 = rats 
receiving 500 mg kg-1 b.w of OPF extract, MET = rats receiving metformin and GB = rats receiving glybenclamide. 
Values represent mean ± SD. *p < 0.05, as compared to baseline.
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activity after 2 (p < 0.05), 4 (p < 0.001) and 6 (p < 0.001) 
h of administration of 500 mg kg-1 OPF (Table 2). The same 
results were observed with metformin after 2 (p < 0.05), 
4 (p < 0.001) and 6 (0.001) h of administration. In post-
prandial diabetic rats, OPF extract started to show a significant 
antihyperglycemic activity at a lower concentration of 
200 mg kg-1 b.w after 4 (p < 0.05) h of administration 
(Table 3). The results were also observed in metformin 
treatment in which a significant antihyperglycemic activity 
were observed after 4 (p < 0.001) and 6 (p < 0.001) h of 
administration. The glybenclamide treated groups however 
did not show any significant antihyperglycemic activity 
in both fasting and post-prandial diabetic rats. From this 
observation, we suggest that the OPF extract is able to 
lower BGL and the mechanism of action of OPF to reduce 
hyperglycemia may be the same as metformin via the 
enhancement of glucose uptake in muscle and reduction 
of hepatic gluconeogenesis. However further evaluations 
at the cellular level are required to confirm this speculation 
and to better understand the mechanisms involved. 
CHRONIC TREATMENT
Evaluation of chronic effects of OPF extract on STZ-
induced diabetic rats was carried out for 28 days period. 
The diabetic rats exhibited a significant loss in body 
weight during the treatment. This could possibly due to 
the excessive catabolism of fats and proteins to produce 
glucose as insulin was not able to utilize the blood glucose 
as an energy source. Furthermore protein content is also 
decreased in muscular tissue due to insulin deficiency in 
diabetic rats (Vats et al. 2004). Treatment with OPF at 500 
mg kg-1 b.w not only significantly prevented weight loss but 
also caused significant weight gain as well as BGL reduction 
in the final week (Figure 1 & 2). This could be possibly due 
to the regeneration and revitalisation of the beta cells by 
OPF extract (Bolkent et al. 2004). Administration of 500 mg 
kg-1 b.w OPF was shown to significantly increase the plasma 
insulin level after four weeks of chronic treatment (Figure 
3). The phytochemicals that exert hypoglycaemic activity 
can be classified as flavonoids, alkaloids, glycosides, 
polysaccharides and saponin. It has been reported that 
certain flavonoids exhibit effective antidiabetic activity 
(Sharma et al. 2000). Therefore it can be suggested 
that flavonoids are present in OPF extract and may be 
responsible for its antihyperglycemic activity in this study. 
However further evaluation is needed to investigate the 
actual bioactive components in OPF to prove this deduction 
and to evaluate the actual mechanisms underlying its 
antihyperglycemic potential. 
CONCLUSION
Regulation of BGL to the normal level is the most important 
in managing diabetes mellitus (Kim et al. 2005). This 
can be achieved through medical nutrition therapy, oral 
hypoglycaemic agents and insulin therapy. Besides, 
the use of antihyperglycaemic plants may also benefit 
diabetic patients in controlling hyperglycemia (Rosalina 
et al. 2011). Based on the results of the present study, 
OPF extract exhibited antihyperglycaemic activity in STZ-
induced diabetic rats at fasting and postprandial states as 
well as during chronic treatment. Therefore it is suggested 
that the OPF extracts have the potential to be developed as 
a new oral antihyperglycemic agent for the treatment of 
diabetes mellitus.
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